Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · March 14, 2023

Outcomes in Biologic-Naïve Patients With Crohn's Disease Receiving Adalimumab Therapy After Resolution of an Intra-Abdominal Abscess

Clinical Gastroenterology and Hepatology


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Gastroenterology and Hepatology
Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID
Clin. Gastroenterol. Hepatol. 2023 Jan 30;[EPub Ahead of Print], Y Bouhnik, G Pineton de Chambrun, J Lambert, M Nachury, P Seksik, R Altwegg, L Vuitton, C Stefanescu, S Nancey, A Aubourg, M Serrero, J Filippi, K Desseaux, S Viennot, V Abitbol, M Boualit, A Bourreille, C Giletta, A Buisson, X Roblin, N Dib, G Malamut, A Amiot, M Fumery, E Louis, Y Elgharabawy, L Peyrin-Biroulet

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading